Inhibitory effects of isoliquiritigenin on the migration and invasion of human breast cancer cells

Kai Lee Wang, Shih Min Hsia, Chia Jung Chan, Full Young Chang, Chih Yang Huang, Da Tian Bau, Paulus S. Wang

Research output: Contribution to journalArticle

47 Citations (Scopus)

Abstract

Introduction: Isoliquiritigenin (ISL) is a natural phenolic compound extracted from licorice. Previous studies have shown that ISL is a potent antioxidant with anti-inflammatory and antitumor activities. The anti-invasive activity of ISL was still unclear. The actual causes of death for most breast cancer patients were due to the tumor metastasis. Attenuating the expression of vascular endothelial growth factor (VEGF) and matrix metalloproteinases (MMPs) is well known to prevent tumor metastasis. Objectives: The purpose of this study is to investigate the effects of ISL on VEGF and MMP expression in highly metastatic human breast cancer cell line, MDA-MB-231. Results: ISL reduced the secretions and protein levels of VEGF. The VEGF upstream regulatory protein, hypoxia-inducible factor 1-alpha (HIF-1α), was also reduced after ISL treatment. Moreover, ISL inhibited the expression and gelatinolytic activity of MMP-2 and MMP-9 which were confirmed by western blot and gelatin zymography assay. Additionally, the anti-migratory activity of ISL was further confirmed by chamber migration assay and wound migration assay. Upstream signaling pathways, including the expression of phosphatidylinositol-3 kinase (PI3K), the phosphorylation of p38 and Akt kinase and NF-κB DNA binding activity, were suppressed by ISL. Conclusion: These findings suggest that ISL suppresses the migration of MDA-MB-231 cells by inhibiting the upstream signaling pathways.

Original languageEnglish
Pages (from-to)337-349
Number of pages13
JournalExpert Opinion on Therapeutic Targets
Volume17
Issue number4
DOIs
Publication statusPublished - Apr 2013

Fingerprint

Cells
Breast Neoplasms
Vascular Endothelial Growth Factor A
Assays
Matrix Metalloproteinases
Tumors
isoliquiritigenin
Phosphatidylinositol 3-Kinase
Neoplasm Metastasis
Glycyrrhiza
Hypoxia-Inducible Factor 1
Phosphorylation
Matrix Metalloproteinase 2
Matrix Metalloproteinase 9
Gelatin
Cause of Death
Neoplasms
Proteins
Anti-Inflammatory Agents
Phosphotransferases

Keywords

  • Breast cancer
  • HIF-1α
  • Isoliquiritigenin
  • Migration
  • VEGF

ASJC Scopus subject areas

  • Drug Discovery
  • Pharmacology
  • Clinical Biochemistry
  • Molecular Medicine

Cite this

Inhibitory effects of isoliquiritigenin on the migration and invasion of human breast cancer cells. / Wang, Kai Lee; Hsia, Shih Min; Chan, Chia Jung; Chang, Full Young; Huang, Chih Yang; Bau, Da Tian; Wang, Paulus S.

In: Expert Opinion on Therapeutic Targets, Vol. 17, No. 4, 04.2013, p. 337-349.

Research output: Contribution to journalArticle

Wang, Kai Lee ; Hsia, Shih Min ; Chan, Chia Jung ; Chang, Full Young ; Huang, Chih Yang ; Bau, Da Tian ; Wang, Paulus S. / Inhibitory effects of isoliquiritigenin on the migration and invasion of human breast cancer cells. In: Expert Opinion on Therapeutic Targets. 2013 ; Vol. 17, No. 4. pp. 337-349.
@article{eec8f3e1569e428db074957d6d0b9ce8,
title = "Inhibitory effects of isoliquiritigenin on the migration and invasion of human breast cancer cells",
abstract = "Introduction: Isoliquiritigenin (ISL) is a natural phenolic compound extracted from licorice. Previous studies have shown that ISL is a potent antioxidant with anti-inflammatory and antitumor activities. The anti-invasive activity of ISL was still unclear. The actual causes of death for most breast cancer patients were due to the tumor metastasis. Attenuating the expression of vascular endothelial growth factor (VEGF) and matrix metalloproteinases (MMPs) is well known to prevent tumor metastasis. Objectives: The purpose of this study is to investigate the effects of ISL on VEGF and MMP expression in highly metastatic human breast cancer cell line, MDA-MB-231. Results: ISL reduced the secretions and protein levels of VEGF. The VEGF upstream regulatory protein, hypoxia-inducible factor 1-alpha (HIF-1α), was also reduced after ISL treatment. Moreover, ISL inhibited the expression and gelatinolytic activity of MMP-2 and MMP-9 which were confirmed by western blot and gelatin zymography assay. Additionally, the anti-migratory activity of ISL was further confirmed by chamber migration assay and wound migration assay. Upstream signaling pathways, including the expression of phosphatidylinositol-3 kinase (PI3K), the phosphorylation of p38 and Akt kinase and NF-κB DNA binding activity, were suppressed by ISL. Conclusion: These findings suggest that ISL suppresses the migration of MDA-MB-231 cells by inhibiting the upstream signaling pathways.",
keywords = "Breast cancer, HIF-1α, Isoliquiritigenin, Migration, VEGF",
author = "Wang, {Kai Lee} and Hsia, {Shih Min} and Chan, {Chia Jung} and Chang, {Full Young} and Huang, {Chih Yang} and Bau, {Da Tian} and Wang, {Paulus S.}",
year = "2013",
month = "4",
doi = "10.1517/14728222.2013.756869",
language = "English",
volume = "17",
pages = "337--349",
journal = "Expert Opinion on Therapeutic Targets",
issn = "1472-8222",
publisher = "Informa Healthcare",
number = "4",

}

TY - JOUR

T1 - Inhibitory effects of isoliquiritigenin on the migration and invasion of human breast cancer cells

AU - Wang, Kai Lee

AU - Hsia, Shih Min

AU - Chan, Chia Jung

AU - Chang, Full Young

AU - Huang, Chih Yang

AU - Bau, Da Tian

AU - Wang, Paulus S.

PY - 2013/4

Y1 - 2013/4

N2 - Introduction: Isoliquiritigenin (ISL) is a natural phenolic compound extracted from licorice. Previous studies have shown that ISL is a potent antioxidant with anti-inflammatory and antitumor activities. The anti-invasive activity of ISL was still unclear. The actual causes of death for most breast cancer patients were due to the tumor metastasis. Attenuating the expression of vascular endothelial growth factor (VEGF) and matrix metalloproteinases (MMPs) is well known to prevent tumor metastasis. Objectives: The purpose of this study is to investigate the effects of ISL on VEGF and MMP expression in highly metastatic human breast cancer cell line, MDA-MB-231. Results: ISL reduced the secretions and protein levels of VEGF. The VEGF upstream regulatory protein, hypoxia-inducible factor 1-alpha (HIF-1α), was also reduced after ISL treatment. Moreover, ISL inhibited the expression and gelatinolytic activity of MMP-2 and MMP-9 which were confirmed by western blot and gelatin zymography assay. Additionally, the anti-migratory activity of ISL was further confirmed by chamber migration assay and wound migration assay. Upstream signaling pathways, including the expression of phosphatidylinositol-3 kinase (PI3K), the phosphorylation of p38 and Akt kinase and NF-κB DNA binding activity, were suppressed by ISL. Conclusion: These findings suggest that ISL suppresses the migration of MDA-MB-231 cells by inhibiting the upstream signaling pathways.

AB - Introduction: Isoliquiritigenin (ISL) is a natural phenolic compound extracted from licorice. Previous studies have shown that ISL is a potent antioxidant with anti-inflammatory and antitumor activities. The anti-invasive activity of ISL was still unclear. The actual causes of death for most breast cancer patients were due to the tumor metastasis. Attenuating the expression of vascular endothelial growth factor (VEGF) and matrix metalloproteinases (MMPs) is well known to prevent tumor metastasis. Objectives: The purpose of this study is to investigate the effects of ISL on VEGF and MMP expression in highly metastatic human breast cancer cell line, MDA-MB-231. Results: ISL reduced the secretions and protein levels of VEGF. The VEGF upstream regulatory protein, hypoxia-inducible factor 1-alpha (HIF-1α), was also reduced after ISL treatment. Moreover, ISL inhibited the expression and gelatinolytic activity of MMP-2 and MMP-9 which were confirmed by western blot and gelatin zymography assay. Additionally, the anti-migratory activity of ISL was further confirmed by chamber migration assay and wound migration assay. Upstream signaling pathways, including the expression of phosphatidylinositol-3 kinase (PI3K), the phosphorylation of p38 and Akt kinase and NF-κB DNA binding activity, were suppressed by ISL. Conclusion: These findings suggest that ISL suppresses the migration of MDA-MB-231 cells by inhibiting the upstream signaling pathways.

KW - Breast cancer

KW - HIF-1α

KW - Isoliquiritigenin

KW - Migration

KW - VEGF

UR - http://www.scopus.com/inward/record.url?scp=84875202575&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84875202575&partnerID=8YFLogxK

U2 - 10.1517/14728222.2013.756869

DO - 10.1517/14728222.2013.756869

M3 - Article

C2 - 23327692

AN - SCOPUS:84875202575

VL - 17

SP - 337

EP - 349

JO - Expert Opinion on Therapeutic Targets

JF - Expert Opinion on Therapeutic Targets

SN - 1472-8222

IS - 4

ER -